Covidien buys Scandius Biomedical
This article was originally published in The Gray Sheet
Acquisition of sports-injury surgical device maker Scandius Biomedical Nov. 8 for undisclosed terms complements Covidien's current sports surgery offerings for soft tissue repair and access, the firm says. Littleton, Mass.-based Scandius makes the Stratis ST femoral fixation and TriTis tibial fixation systems, which include instrumentation and non-absorbable and bioabsorbable polymer implants, for arthroscopic reconstruction of the anterior cruciate ligament. Covidien, a diversified device, diagnostic and drug manufacturer, completed its spin-off from parent firm Tyco International in June (1"The Gray Sheet" July 9, 2007, p. 8)
You may also be interested in...
Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.